department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Aurlumyn · pharmadog

pharmadog
drugs
Aurlumyn

drug

patient view →

iloprost

Marketedupdated 2mo ago

by BTG International Inc

Approved

community read0 votes

all catalysts(1)

phase 2 completion · 1

phase 2 completion

University of Sao Paulo General Hospital — iloprost (Phase II Trial Completion)

News(0)

no news has mentioned this drug yet

brand

Aurlumyn

generic

iloprost

indication

Skin Infections

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Feb 13, 2027

221 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (2)

Jul 18, 2044method-of-use (U-4263)US 12409183
Aug 6, 2041formulationUS 12409184

FDA exclusivities (2)

Feb 13, 2031ODE-465Orphan Drug (7y)4.6y
Feb 13, 2027NPNP221d

Data sources

ClinicalTrials.gov

last refreshed 32m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 4

companyUniversity of Sao Paulo General Hospital1 co-mentions · 1 sources
tagCardiology1 co-mentions · 1 sources
tagPulmonology1 co-mentions · 1 sources
tagHypertension1 co-mentions · 1 sources

Trials studying iloprost

phase3Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)completedn=198
phase2Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)completedn=34
phase3The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertensionterminatedn=67
phase3Iloprost Power 15 in Pulmonary Arterial Hypertensioncompletedn=64
—Ventavis® Registry Protocolterminatedn=148
—Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)completedn=282
phase3Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failurecompletedn=279
phase4Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertensionterminatedn=27

more trials →